Internal Medicine, Endocrinology, Diabetes, & Metabolism · New York, NY
NPI
1619951175
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
180 Park Row, West Lobby Suite
New York, NY, 10038
Phone (212) 267-2481
Medicare paid, 2024
$27K
495 services
Medicare patients, 2024
164
Average age 77
Drug cost, 2024
$1.9M
5,842 prescriptions
Company payments, 2023
$118
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Howard E Huey was code 99214 (office e&m - established), 252 times for 144 patients. In total Howard E Huey billed 495 services in 9 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 252 | 144 | $90.92 | $23K |
| 82962 Clinical Chemistry | Office | 193 | 95 | $3.15 | $608 |
| 99215 Office E&M - Established | Office | 17 | 13 | $155.26 | $2,640 |
| 99213 Office E&M - Established | Office | 15 | 15 | $60.63 | $910 |
By year: 2022 $60K for 930 services; 2023 $54K for 849 services; 2024 $27K for 495 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 193 | 95 | $3.15 | $608 |
Medicare prescription drug claims, 2024
In 2024, the drug Howard E Huey prescribed most often to Medicare patients was Metformin Hcl Er (Metformin Hcl), with 568 prescriptions and refills. In total Howard E Huey wrote 5,842 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Er Metformin Hcl | 568 | 1,118 | 138 | $5,111 |
| Levothyroxine Sodium Generic | 449 | 942 | 113 | $3,303 |
| Ozempic Semaglutide | 390 | 574 | 74 | $549K |
| Glimepiride Generic | 295 | 518 | 57 | $1,413 |
| Atorvastatin Calcium Generic | 240 | 536 | 67 | $1,631 |
| Synthroid Levothyroxine Sodium | 194 | 377 | 40 | $13K |
| Farxiga Dapagliflozin Propanediol | 185 | 296 | 42 | $163K |
| Jardiance Empagliflozin | 167 | 263 | 39 | $148K |
| Losartan Potassium Generic | 165 | 382 | 46 | $1,223 |
| Methimazole Generic | 147 | 254 | 32 | $1,609 |
| Januvia Sitagliptin Phosphate | 113 | 206 | 33 | $110K |
| Tradjenta Linagliptin | 113 | 149 | 25 | $75K |
| Rybelsus Semaglutide | 105 | 169 | 27 | $162K |
| Rosuvastatin Calcium Generic | 102 | 225 | 31 | $835 |
| Ezetimibe Generic | 98 | 190 | 22 | $1,322 |
Brand drugs: 2,261 claims; generic drugs: 3,231 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Howard E Huey $118 ($118 in general payments such as food, travel and fees) from 1 company. The largest payer was Horizon Therapeutics plc with $118.
| Company | Payments | Amount |
|---|---|---|
| Horizon Therapeutics plc AMGN | 1 | $118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.